GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $155,000 | -13.4% | 442,650 | +15.1% | 0.00% | – |
| Q2 2016 | $179,000 | -66.4% | 384,550 | -1.7% | 0.00% | -100.0% |
| Q1 2016 | $532,000 | +20.6% | 391,305 | +30.6% | 0.00% | 0.0% |
| Q4 2015 | $441,000 | -5.2% | 299,713 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $465,000 | -7.4% | 294,351 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $502,000 | +32.5% | 295,351 | +8.3% | 0.00% | 0.0% |
| Q1 2015 | $379,000 | +14.8% | 272,819 | +24.7% | 0.00% | 0.0% |
| Q4 2014 | $330,000 | -26.5% | 218,819 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $449,000 | -32.1% | 217,888 | +0.9% | 0.00% | -50.0% |
| Q2 2014 | $661,000 | +23.3% | 216,051 | +0.7% | 0.00% | +100.0% |
| Q1 2014 | $536,000 | -41.6% | 214,451 | +15.9% | 0.00% | -50.0% |
| Q4 2013 | $918,000 | +128.9% | 185,051 | +4.9% | 0.00% | +100.0% |
| Q3 2013 | $401,000 | +24.1% | 176,451 | +21.3% | 0.00% | 0.0% |
| Q2 2013 | $323,000 | – | 145,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |